AFC-HD AMS Life Science Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	22.2yrs
Gemiddelde ambtstermijn bestuur	4yrs

Recente managementupdates

Recent updates

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

Apr 17

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

Apr 29

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Apr 14

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

Feb 20

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

Feb 04

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Jan 17

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

Dec 29

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 02

CEO

AFC-HD AMS Life Science heeft geen CEO, of we hebben geen gegevens over hen.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Nobue Hamabe	Accounting Manager & Director	22.2yrs	geen gegevens	0.17% ¥ 19.8m
Naoya Unno	GM of Technical Development Division & Director	22.2yrs	geen gegevens	0.23% ¥ 27.4m
Shigenori Fukuchi	Senior MD	19yrs	geen gegevens	0.29% ¥ 34.0m

22.2yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 2927 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 22.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Nobue Hamabe	Accounting Manager & Director	2yrs	geen gegevens	0.17% ¥ 19.8m
Naoya Unno	GM of Technical Development Division & Director	21.2yrs	geen gegevens	0.23% ¥ 27.4m
Shigenori Fukuchi	Senior MD	21.2yrs	geen gegevens	0.29% ¥ 34.0m
Takehiko Asayama	Chairman	23.3yrs	JP¥234.60m	8.4% ¥ 981.0m
Hiroshi Unno	Independent Outside Director	4yrs	geen gegevens	0.022% ¥ 2.6m
Shigeo Minakata	Director	3yrs	geen gegevens	0.041% ¥ 4.7m
Shunji Sasahara	Director	4yrs	geen gegevens	0.036% ¥ 4.1m

4.0yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2927 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).

AFC-HD AMS Life Science Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 26, 2024

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

No independent directors

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

No independent directors

Recent updates

Full year 2024 earnings released: EPS: JP¥88.62 (vs JP¥78.47 in FY 2023)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 26, 2024

New major risk - Financial data availability

Upcoming dividend of JP¥15.00 per share

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2024 Results on Oct 15, 2024

Investor sentiment deteriorates as stock falls 16%

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) agreed to acquire Rabbit Kyuko K.K. from Shinichi Matsunaga for ¥1.

Third quarter 2024 earnings released: EPS: JP¥19.98 (vs JP¥19.05 in 3Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2024 Results on Jul 16, 2024

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

First half dividend of JP¥15.00 announced

Second quarter 2024 earnings released: EPS: JP¥22.99 (vs JP¥18.05 in 2Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2024 Results on Apr 15, 2024

Upcoming dividend of JP¥15.00 per share

First quarter 2024 earnings released: EPS: JP¥22.76 (vs JP¥11.40 in 1Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2024 Results on Jan 12, 2024

Full year 2023 earnings released: EPS: JP¥77.12 (vs JP¥52.31 in FY 2022)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

Upcoming dividend of JP¥15.00 per share at 3.0% yield

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2023 Results on Oct 13, 2023

Third quarter 2023 earnings released: EPS: JP¥19.05 (vs JP¥16.25 in 3Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2023 Results on Jul 14, 2023

Second quarter 2023 earnings released: EPS: JP¥18.05 (vs JP¥10.79 in 2Q 2022)

Upcoming dividend of JP¥12.50 per share at 3.1% yield

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2023 Results on Apr 14, 2023

Investor sentiment improves as stock rises 16%

First quarter 2023 earnings released: EPS: JP¥11.40 (vs JP¥11.03 in 1Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) agreed to acquire a 51% stake in 5SPRO Joint Stock Company.

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2023 Results on Jan 13, 2023

No independent directors

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2022 Results on Oct 14, 2022

Upcoming dividend of JP¥15.00 per share

Third quarter 2022 earnings released: EPS: JP¥16.25 (vs JP¥45.13 in 3Q 2021)

AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2022 Results on Jul 15, 2022

No independent directors

AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022

Second quarter 2022 earnings released: EPS: JP¥10.79 (vs JP¥25.92 in 2Q 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2022 Results on Apr 14, 2022

Upcoming dividend of JP¥15.00 per share

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥107 (vs JP¥48.07 in FY 2020)

Upcoming dividend of JP¥15.00 per share

Third quarter 2021 earnings released: EPS JP¥45.13 (vs JP¥6.33 in 3Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 2021

Investor sentiment improved over the past week

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Second quarter 2021 earnings released: EPS JP¥25.92 (vs JP¥13.58 in 2Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2021

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

New 90-day high: JP¥1,115

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

New 90-day high: JP¥1,088

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥26.88

New 90-day high: JP¥798

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

AFC-HD AMS Life Science Co., Ltd. Announces Year End Dividend for the Fiscal Year Ended August 31, 2020, Payable on November 26, 2020